Results 181 to 190 of about 41,423 (288)

Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive–compulsive disorder [PDF]

open access: gold, 2019
Mircea Polosan   +7 more
openalex   +1 more source

The Precuneus Region Drives Brain Network Changes in Tremor‐Dominant Parkinson's Disease: Insights from a Morphological Causal Analysis

open access: yesMedComm, Volume 6, Issue 11, November 2025.
We uncovered a unique morphological progression pattern in tremor‐dominant Parkinson's disease. Based on this, a machine‐learning model combining cortical volume features with clinical assessments was developed to reliably predict deep brain stimulation (DBS) outcomes.
Moxuan Zhang   +18 more
wiley   +1 more source

A comparison of electrophysiological microrecording versus automatic MR-based segmentation to determine subthalamic nucleus boundaries. [PDF]

open access: yesActa Neurochir (Wien)
de Laurentis C   +6 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 11, Page 1764-1773, November 2025.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister   +11 more
wiley   +1 more source

Is the Subthalamic Nucleus Sleeping Under Nitrous Oxide-Ketamine General Anesthesia? [PDF]

open access: yesEur J Neurosci
Erdman HB   +18 more
europepmc   +1 more source

Selection of Optimal Programming Contacts Based on Local Field Potential Recordings From Subthalamic Nucleus in Patients With Parkinson's Disease

open access: green, 2010
Nuri F. Ince   +7 more
openalex   +2 more sources

Subjective Well‐Being and Its Predictors in Parkinson's Disease and Dystonia: A Comparative Study

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 11, Page 1792-1800, November 2025.
Abstract Background Quality of life (QoL) is a commonly used outcome measure in people with chronic neurological diseases (CND). As valuable as QoL is, it does not take into account aspects of subjective well‐being (SWB) such as subjective happiness, meaning in life, life satisfaction and hope; all constructs that are considered central to well‐being ...
Suzette Shahmoon   +5 more
wiley   +1 more source

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 11, Page 1774-1783, November 2025.
Abstract Background Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Maria Teresa Pellecchia   +41 more
wiley   +1 more source

Home - About - Disclaimer - Privacy